Stability of erythropoietin repackaging in polypropylene syringes for clinical use

• Autores principales: Angela Marsili (Autor), Giorgia Puorro (Autor), Chiara Pane (Autor), Anna de Rosa (Autor), Giovanni Defazio (Autor), Carlo Casali (Autor), Antonio Cittadini (Autor), Giuseppe de Michele (Autor), Brunello Ettore Florio (Autor), Alessandro Filla (Autor), Francesco Saccà (Autor)
• Formato: Libro
• Publicado: Elsevier, 2017-02-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Introduction: Epoetin alfa (Eprex®) is a subcutaneous, injectable formulation of short half-life recombinant human erythropoietin (rHuEPO). To current knowledge there are no published studies regarding the stability of rHuEPO once repackaging occurs (r-EPO) for clinical trial purposes. Materials and...